tirzepatide helps inflammation isn't a weight drug. It's an drug that happens to help with weight. That's why it's quietly changing the MCAS conversation. Dual GLP-1 / GIP agonist. GLP-1 slows gut motility Tirzepatide for Weight Loss (Fat

Pennsylvanias Medicaid spending for GLP-1s like Ozempic, Wegovy, and Zepbound exploded to an estimated $1.3 billion last year from $233 million in 2022, the year before Medicaid started covering the drugs for obesity

They support fat metabolism , particularly around the midsection, while helping maintain lean muscle mass

Articles like how long reconstituted peptides last in the fridge provide more specific data on semaglutide stability timelines

Consumers on these medications tend to purchase fewer items but spend more on high-margin, functional foods and supplements, with an emphasis on portion control

Price: $595 SLU-PP-332 May support exercise-mimetic pathways, fat oxidation, endurance, and mitochondrial wellness